| Stenting of transplant renal artery stenosis: outcome in a single center study. | |
| | |
MedLine Citation:
|
PMID: 18670375 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIM: Transplant renal artery stenosis (TRAS) is the most frequent vascular complication following transplantation and is a potential curable cause of resistant hypertension, allograft dysfunction, and graft loss. Percutaneous angioplasty (PTA) is the treatment of choice, but the incidence of restenosis may be as high as 35%. Alternative treatment option combines the angioplastic procedure with the placement of a stent. The aim of this study was to evaluate retrospectively the clinical outcome of 30 patients with TRAS or post-PTA recurrent TRAS between 1991 and 2006 treated by endoluminal stenting. Primary outcomes of this study were survival rate, percentage of restenosis and lost of the graft. Secondary outcomes were: reduction of blood pressure, creatinine levels and number of antihypertensive medications. METHODS: From May 1991 to May 2006 a retrospective review of stent placement procedures for TRAS was performed. Reviewed parameters included: technical success, arterial blood pressure and number of antihypertension medications, serum creatinine level before and after intervention. Thirty-two interventions in 30 allografts were carried out. Allograft survival rate was estimated using the Kaplan-Meier METHODS: RESULTS: The technical success rate of stenting was 100% with a single major complication event (a puncture site pseudoaneurysm). Mean follow-up time was 7.1 years; of the 30 allograft that underwent stent placement, all were patent at the last follow-up, with five restenosis (15.6%) of which only one needed to be retreated endoluminally. A reduction of the mean serum creatinine levels and of the number of blood pressure medications was observed. There was no difference in the survival curve of the grafts without TRAS compared to those with stenting treated TRAS. CONCLUSION: The treatment of the TRAS with selective or primary stenting is safe with a long-term patency rate. The efficacy of the stenting in this retrospective study is suggested by a decrease in mean systolic and diastolic blood pressure, serum creatinine levels and number of blood pressure medications. |
| | |
Authors:
|
S Valpreda; M Messina; C Rabbia |
Related Documents
:
|
14613915 - Variation of mechanical properties along the length of the aorta in c57bl/6 mice. 9650905 - Percutaneous fenestration of type b aortic dissection for decompression of false lumen ... 18381145 - Tear size and location impacts false lumen pressure in an ex vivo model of chronic type... 6518285 - Volume elasticity, modulus of elasticity and compliance of normal and arteriosclerotic ... 1012105 - The design of pressure monitoring devices: infection control considerations. 15035605 - Effects of chaotropic and kosmotropic cosolvents on the pressure-induced unfolding and ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Journal of cardiovascular surgery Volume: 49 ISSN: 0021-9509 ISO Abbreviation: J Cardiovasc Surg (Torino) Publication Date: 2008 Oct |
Date Detail:
|
Created Date: 2008-08-01 Completed Date: 2008-12-16 Revised Date: 2009-11-11 |
Medline Journal Info:
|
Nlm Unique ID: 0066127 Medline TA: J Cardiovasc Surg (Torino) Country: Italy |
Other Details:
|
Languages: eng Pagination: 565-70 Citation Subset: IM |
Affiliation:
|
Department of Vascular and Interventional Radiology, San Giovanni Battista Hospital, corso Bramante 88, Turin, Italy. valpinax@hotmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Angioplasty, Balloon / methods* Female Humans Kidney Transplantation / adverse effects* Male Middle Aged Renal Artery Obstruction / etiology, surgery*, ultrasonography Retrospective Studies Stents* Survival Rate Treatment Outcome Ultrasonography, Doppler, Color |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Invasive treatment for renovascular disease. A twenty year experience from a population based regist...
Next Document: Embolic protection for renal artery stenting.